Promotor polymorphisms of plasminogen activator inhibitor-1 and other thrombophilic genotypes in cerebral venous thrombosis: A case-control study in adults

Journal of Neurology

Volumn 259, Issue 11, 2012, Pages 2287-2292

  Ringelstein, Marius ^a   Jung, Alexander ^b   Berger, Klaus ^c   Stoll, Monika ^c   Madlener, Katharina ^d   Klötzsch, Christof ^e   Schlachetzki, Felix ^f   Stolz, Erwin ^g  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^c UNIVERSITY OF MÜNSTER   (Germany)

^d KERCKHOFF HEART CENTER   (Germany)

^e Hegau Bodensee Klinikum   (Germany)

^f UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^g CaritasKlinikum St Theresia ^*  (Germany)

Author keywords

4G 5G alleles; Cerebral venous thrombosis; PAI 1 polymorphisms; Thrombophilic risk factors

Indexed keywords

DNA; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTHROMBIN;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; CASE CONTROL STUDY; CEREBRAL SINUS THROMBOSIS; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RISK FACTOR; SEX DIFFERENCE; THROMBOPHILIA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; GENOTYPE; HUMANS; INTRACRANIAL THROMBOSIS; MALE; MIDDLE AGED; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; VENOUS THROMBOSIS; YOUNG ADULT;

EID: 84868196852     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-012-6477-7     Document Type: Article

References (37)

1. Akhter MS, Biswas A, Ranjan R, Meena A, Yadav BK, Sharma A, Saxena R (2010) Plasminogen activator inhibitor-1 (PAI-1) gene 4G/5G promoter polymorphism is seen in higher frequency in the Indian patients with deep vein thrombosis. Clin Appl Thromb Hemost 16:184-188
2. Attia J, Thakkinstian A, Wang Y, Lincz L, Parsons M, Sturm J, McGettigan P, Scott R, Meldrum C, Levi C (2007) The PAI-1 4G/5G gene polymorphism and ischemic stroke: an association study and meta-analysis. J Stroke Cerebrovasc Dis 16:173-179 (Pubitemid 47048923)
3. Bedencic M, Bozic M, Peternel P, Stegnar M (2008) Major and potential prothrombotic genotypes in patients with venous thrombosis and in healthy subjects from Slovenia. Pathophysiol Haemost Thromb 36:58-63
4. Bousser MG (2000) Cerebral venous thrombosis: diagnosis and management. J Neurol 247:252-258
5. Bousser MG, Ferro JM (2007) Cerebral venous thrombosis: an update. Lancet Neurol 6:162-170 (Pubitemid 46097542)
6. Chen YL, Zhang JX, Wang PX, Cui RZ, Zhao FM, Mao YM, Li JY, Bi YY, Li H (2005) Association of 4G/5G polymorphism in PAI1 promoter with PAI1 level in deep vein thrombosis. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 22:624-627 (Pubitemid 41820175)
7. Cheng S, Grow MA, Pallaud C, Klitz W, Erlich HA, Visvikis S, Chen JJ, Pullinger CR, Malloy MJ, Siest G, Kane JP (1999) A multilocus genotyping assay for candidate markers of cardiovascular disease risk. Genome Res 9:936-949 (Pubitemid 29525202)
8. Dentali F, Ageno W (2010) Cerebral vein thrombosis. Intern Emerg Med 5:27-32
9. Dentali F, Gianni M, Crowther MA, Ageno W (2006) Natural history of cerebral vein thrombosis: a systematic review. Blood 108:1129-1134 (Pubitemid 44232006)
10. Festa A, D'Agostino R Jr, Rich SS, Jenny NS, Tracy RP, Haffner SM (2003) Promoter (4G/5G) plasminogen activator inhibitor-1 genotype and plasminogen activator inhibitor-1 levels in blacks, Hispanics, and non-Hispanic whites: the Insulin Resistance Atherosclerosis Study. Circulation 107:2422-2427 (Pubitemid 36605223)
11. Friedrichs F, Brescianini S, Annese V, Latiano A, Berger K, Kugathasan S, Broeckel U, Nikolaus S, Daly MJ, Schreiber S, Rioux JD, Stoll M (2006) Evidence of transmission ratio distortion of DLG5 R30Q variant in general and implication of an association with Crohn disease in men. Hum Genet 119:305-311
12. Gohil R, Peck G, Sharma P (2009) The genetics of venous thromboembolism. A meta-analysis involving approximately 120,000 cases and 180,000 controls. Thromb Haemost 102:360-370
13. Gori AM, Marcucci R, Fatini C, Gensini F, Sticchi E, Sodi A, Cappelli S, Menchini U, Gensini GF, Abbate R, Prisco D (2004) Impaired fibrinolysis in retinal vein occlusion: a role for genetic determinants of PAI-1 levels. Thromb Haemost 92:54-60 (Pubitemid 39010867)
14. Hermans PW, Hazelzet JA (2005) Plasminogen activator inhibitor type 1 gene polymorphism and sepsis. Clin Infect Dis 41(Suppl 7):S453-S458 (Pubitemid 41598305)
15. Hoekstra T, Geleijnse JM, Kluft C, Giltay EJ, Kok FJ, Schouten EG (2003) 4G/4G genotype of PAI-1 gene is associated with reduced risk of stroke in elderly. Stroke 34:2822-2828 (Pubitemid 37517749)
16. Jood K, Ladenvall P, Tjarnlund-Wolf A, Ladenvall C, Andersson M, Nilsson S, Blomstrand C, Jern C (2005) Fibrinolytic gene polymorphism and ischemic stroke. Stroke 36:2077-2081 (Pubitemid 41429223)
17. Junker R, Nabavi DG, Wolff E, Ludemann P, Nowak-Gottl U, Kase M, Baumer R, Ringelstein EB, Assmann G (1998) Plas-minogen activator inhibitor-1 4G/4G-genotype is associated with cerebral sinus thrombosis in factor V Leiden carriers. Thromb Haemost 80:706-707 (Pubitemid 28479367)
18. Kosch A, Junker R, Kurnik K, Schobess R, Gunther G, Koch H, Nowak-Gottl U (2000) Prothrombotic risk factors in children with spontaneous venous thrombosis and their asymptomatic parents: a family study. Thromb Res 99:531-537 (Pubitemid 30642732)
19. Lichy C, Kloss M, Reismann P, Genius J, Grau A, Reuner K (2007) No evidence for plasminogen activator inhibitor 1 4G/4G genotype as risk factor for cerebral venous thrombosis. J Neurol 254:1124-1125 (Pubitemid 47353405)
20. Mansilha A, Araujo F, Severo M, Sampaio SM, Toledo T, Albuquerque R (2005) Genetic polymorphisms and risk of recurrent deep venous thrombosis in young people: prospective cohort study. Eur J Vasc Endovasc Surg 30:545-549 (Pubitemid 41472428)
21. Marjot T, Yadav S, Hasan N, Bentley P, Sharma P (2011) Genes associated with adult cerebral venous thrombosis. Stroke 42:913-918
22. Masuhr F, Mehraein S, Einhaupl K (2004) Cerebral venous and sinus thrombosis. J Neurol 251:11-23 (Pubitemid 38210485)
23. Meltzer ME, Lisman T, de Groot PG, Meijers JC, le CS, Doggen CJ, Rosendaal FR (2010) Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI-1. Blood 116:113-121
24. Nowak-Gottl U, Strater R, Kosch A, von EA, Schobess R, Luigs P, Nabel P, Vielhaber H, Kurnik K, Junker R (2001) The plas-minogen activator inhibitor (PAI)-1 promoter 4G/4G genotype is not associated with ischemic stroke in a population of German children. Childhood Stroke Study Group. Eur J Haematol 66:57-62 (Pubitemid 32099411)
25. Ny T, Sawdey M, Lawrence D, Millan JL, Loskutoff DJ (1986) Cloning and sequence of a cDNA coding for the human beta-migrating endothelial-cell-type plasminogen activator inhibitor. Proc Natl Acad Sci USA 83:6776-6780 (Pubitemid 16002316)
26. Onalan O, Balta G, Oto A, Kabakci G, Tokgozoglu L, Aytemir K, Altay C, Gurgey A, Nazli N (2008) Plasminogen activator inhibitor-1 4G4G genotype is associated with myocardial infarction but not with stable coronary artery disease. J Thromb Thrombolysis 26:211-217
27. Ozyurek E, Balta G, Degerliyurt A, Parlak H, Aysun S, Gurgey A (2007) Significance of factor V, prothrombin, MTHFR, and PAI-1 genotypes in childhood cerebral thrombosis. Clin Appl Thromb Hemost 13:154-160 (Pubitemid 46548366)
28. Ridker PM, Hennekens CH, Lindpaintner K, Stampfer MJ, Miletich JP (1997) Arterial and venous thrombosis is not associated with the 4G/5G polymorphism in the promoter of the plasminogen activator inhibitor gene in a large cohort of US men. Circulation 95:59-62 (Pubitemid 27029943)
29. Sartori MT, Danesin C, Saggiorato G, Tormene D, Simioni P, Spiezia L, Patrassi GM, Girolami A (2003) The PAI-1 gene 4G/5G polymorphism and deep vein thrombosis in patients with inherited thrombophilia. Clin Appl Thromb Hemost 9:299-307 (Pubitemid 37414120)
30. Schulman S, Wiman B (1996) The significance of hypofibrinol-ysis for the risk of recurrence of venous thromboembolism. Duration of Anticoagulation (DURAC) Trial Study Group. Thromb Haemost 75:607-611 (Pubitemid 26141443)
31. Segui R, Estelles A, Mira Y, Espana F, Villa P, Falco C, Vaya A, Grancha S, Ferrando F, Aznar J (2000) PAI-1 promoter 4G/5G genotype as an additional risk factor for venous thrombosis in subjects with genetic thrombophilic defects. Br J Haematol 111:122-128
32. Tsantes AE, Nikolopoulos GK, Bagos PG, Bonovas S, Kopterides P, Vaiopoulos G (2008) The effect of the plasminogen activator inhibitor-1 4G/5G polymorphism on the thrombotic risk. Thromb Res 122:736-742
33. Tsantes AE, Nikolopoulos GK, Bagos PG, Rapti E, Mantzios G, Kapsimali V, Travlou A (2007) Association between the plas-minogen activator inhibitor-1 4G/5G polymorphism and venous thrombosis. A meta-analysis. Thromb Haemost 97:907-913 (Pubitemid 46939203)
34. Vennemann MM, Hummel T, Berger K (2008) The association between smoking and smell and taste impairment in the general population. J Neurol 255:1121-1126
35. Wiklund PG, Nilsson L, Ardnor SN, Eriksson P, Johansson L, Stegmayr B, Hamsten A, Holmberg D, Asplund K (2005) Plas-minogen activator inhibitor-1 4G/5G polymorphism and risk of stroke: replicated findings in two nested case-control studies based on independent cohorts. Stroke 36:1661-1665 (Pubitemid 41098758)
36. Ye Z, Liu EH, Higgins JP, Keavney BD, Lowe GD, Collins R, Danesh J (2006) Seven haemostatic gene polymorphisms in coronary disease: meta-analysis of 66,155 cases and 91,307 controls. Lancet 367:651-658 (Pubitemid 43289155)
37. Zoller B, de Garcia FP, Dahlback B (1998) A common 4G allele in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene as a risk factor for pulmonary embolism and arterial thrombosis in hereditary protein S deficiency. Thromb Haemost 79:802-807 (Pubitemid 28163858)